The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 27, 2018
Filed:
Jul. 21, 2017
Applicant:
The Regents of the University of California, Oakland, CA (US);
Inventors:
Ranjan Dohil, San Diego, CA (US);
Jerry Schneider, La Jolla, CA (US);
Assignee:
The Regents of the University of California, Oakland, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 33/08 (2006.01); A61K 31/194 (2006.01); A61K 9/28 (2006.01); A61K 9/50 (2006.01); A61K 9/48 (2006.01); A61K 9/00 (2006.01); A61K 31/145 (2006.01); A61K 31/13 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/194 (2013.01); A61K 9/0053 (2013.01); A61K 9/1605 (2013.01); A61K 9/284 (2013.01); A61K 9/288 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01); A61K 9/2873 (2013.01); A61K 9/4808 (2013.01); A61K 9/5005 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5047 (2013.01); A61K 9/5057 (2013.01); A61K 9/5063 (2013.01); A61K 31/13 (2013.01); A61K 31/145 (2013.01);
Abstract
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.